Evidence map›Paper›PMID 41426864›Full record

ArticleCureus2025

Beyond the Psychiatric Lens: Difficulties in Diagnosing Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Psychiatric Presentation.

Madeline Bleier, Chelsea Corinaldi, Carmen Nichita, Alexander Banashkevich, Luba Leontieva

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Madeline BleierPsychiatry and Behavioral Sciences, State University of New York Upstate Medical University, Syracuse, USA.
Chelsea CorinaldiPsychiatry and Behavioral Sciences, State University of New York Upstate Medical University, Syracuse, USA.
Carmen NichitaPsychiatry and Behavioral Sciences, State University of New York Upstate Medical University, Syracuse, USA.
Alexander BanashkevichRadiation Oncology, State University of New York Upstate Medical University, Syracuse, USA.
Luba LeontievaPsychiatry and Behavioral Sciences, State University of New York Upstate Medical University, Syracuse, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder that predominantly affects young women and is often associated with ovarian teratomas. We describe a 21-year-old woman with a history of anxiety who initially presented with agitation, abnormal movements, and headaches. Her symptoms were first attributed to psychiatric causes, leading to multiple emergency department visits and eventual psychiatric admission. Despite escalating antipsychotic treatment, her condition rapidly worsened, marked by severe agitation, hypersexuality, and nihilistic delusions. Two weeks into her hospitalization, positive serum anti-NMDAR antibodies and pelvic imaging revealing a right ovarian teratoma prompted a shift in management to immunotherapy and surgical resection. She subsequently experienced significant cognitive recovery. This case highlights how the predominance of psychiatric symptoms in women with anti-NMDAR encephalitis can obscure timely recognition of the underlying neurologic disease. Early consideration of autoimmune encephalitis in young women with abrupt, treatment-resistant psychiatric symptoms is critical to avoid delays in diagnosis and improve outcomes.

Indexed as

anti-nmdar encephalitisanti-n-methyl-d-aspartate receptor encephalitisautoimmune encephalitisfirst episode psychosisneuropsychiatric symptomsovarian teratomayoung adult female

Identifiers

PMID41426864
PMCPMC12715975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.